4MDA
Structure of Mos1 transposase catalytic domain and Raltegravir with Mn
Summary for 4MDA
Entry DOI | 10.2210/pdb4mda/pdb |
Related | 2F7T 3HOS 3HOT 4MDB |
Descriptor | Mariner Mos1 transposase, MANGANESE (II) ION, N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(1-methyl-1-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}ethyl)-6-oxo-1,6-di hydropyrimidine-4-carboxamide, ... (4 entities in total) |
Functional Keywords | rnase-h fold, ddd motif, recombinase, dna transposition, dna integration, transposon dna, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor |
Biological source | Drosophila mauritiana (Fruit fly) |
Cellular location | Nucleus (Probable): Q7JQ07 |
Total number of polymer chains | 1 |
Total formula weight | 27445.85 |
Authors | Richardson, J.M. (deposition date: 2013-08-22, release date: 2014-01-22, Last modification date: 2023-09-20) |
Primary citation | Wolkowicz, U.M.,Morris, E.R.,Robson, M.,Trubitsyna, M.,Richardson, J.M. Structural Basis of Mos1 Transposase Inhibition by the Anti-retroviral Drug Raltegravir. Acs Chem.Biol., 9:743-751, 2014 Cited by PubMed: 24397848DOI: 10.1021/cb400791u PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.7 Å) |
Structure validation
Download full validation report